| Acquired by | Boston Scientific |
| Date | 11/10 |
| Terms | Cash and Stock |
| Website | sadramedical.com |
| Category | BioTech |
| Employees | |
| Description | Aortic Valve Disease Therapy Innovator |
| Total | $58M |
| Series A, 6/04 Pequot Capital Onset Ventures Schroder Ventures | $9M |
| Series B, 10/06 Oakwood Medical Investors Pequot Capital Onset Ventures SV Life Sciences Boston Scientific | $19M |
| Series C, 5/09 Accuitive Medical Ventures Boston Scientific Finistere Ventures FirstMark Capital Onset Ventures SV Life Sciences Oakwood Medical Investors | $30M |
Sadra Medical is exploring new minimally invasive alternatives to traditional surgical valve replacement. The company hopes that devices allowing such procedural advances will facilitate and enhance treatment of aortic valve disease.
